Published in Hypertension on May 01, 1991
New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism. Hypertension (2009) 1.28
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest (1995) 1.22
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Br J Pharmacol (1992) 1.12
Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci U S A (1991) 1.11
Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest (1992) 1.09
Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest (1993) 1.03
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br J Pharmacol (1993) 1.02
Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes. PLoS One (2011) 1.00
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol (1991) 0.95
Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci U S A (1993) 0.95
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Br J Pharmacol (1993) 0.91
Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol (1992) 0.90
Angiotensin peptides and lung cancer. Curr Cancer Drug Targets (2011) 0.89
Angiotensin II enhances connecting tubule glomerular feedback. Hypertension (2010) 0.85
Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells. Biochem J (1996) 0.84
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174. Br J Pharmacol (1992) 0.83
Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br J Pharmacol (1995) 0.82
Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. J Clin Invest (1993) 0.80
Development of polyclonal antibodies against angiotensin type 2 receptors. Proc Natl Acad Sci U S A (1993) 0.79
Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats. Br J Pharmacol (1993) 0.79
Angiotensin II increased neuronal stem cell proliferation: role of AT2R. PLoS One (2013) 0.78
Characterization of AT2 receptor expression in NIH 3T3 fibroblasts. Cell Mol Neurobiol (1999) 0.78
Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro. Br J Pharmacol (1992) 0.77
Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells. Br J Pharmacol (1994) 0.76
Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells. Br J Pharmacol (1994) 0.76
Activation of AT1 angiotensin receptors induces DNA synthesis in a rat intestinal epithelial (RIE-1) cell line. Biochem J (1994) 0.76
Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo. Br J Pharmacol (1993) 0.75
Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney. Proc Natl Acad Sci U S A (1993) 0.75
Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells. Br J Pharmacol (1995) 0.75
Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine. Br J Pharmacol (1993) 0.75
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
Defective angiogenesis in mice lacking endoglin. Science (1999) 4.40
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev (1977) 3.70
A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc Natl Acad Sci U S A (1995) 3.02
Hormonal regulation of peptide receptors and target cell responses. Nature (1979) 2.79
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem (1990) 2.41
Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest (1998) 2.41
The purification and properties of p-cresol-(acceptor) oxidoreductase (hydroxylating), a flavocytochrome from Pseudomonas putida. Biochem J (1977) 2.39
Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension (1982) 2.32
Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J Biol Chem (1987) 2.24
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology (1972) 2.13
Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis. J Clin Pathol (2000) 2.02
Molecular biology of angiotensinogen. Hypertension (1991) 1.97
Angiotensin II-forming pathways in normal and failing human hearts. Circ Res (1990) 1.97
Cardiac angiosarcomas. A review and a case report. Cancer (1986) 1.90
Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem (2001) 1.86
A social indicator of access to medical care. J Health Soc Behav (1975) 1.83
Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol (2000) 1.82
Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res (1982) 1.79
A prospective randomized study of neurocognitive function and s-100 protein after antegrade or retrograde brain perfusion with hypothermic arrest for aortic surgery. J Thorac Cardiovasc Surg (2000) 1.78
Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem (1992) 1.76
Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol (1980) 1.75
Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities. Arch Int Pharmacodyn Ther (1980) 1.69
Angiotensin receptors and their antagonists. N Engl J Med (1996) 1.69
Characterization of inositol 1,4,5-trisphosphate receptors and calcium mobilization in a hepatic plasma membrane fraction. J Biol Chem (1988) 1.65
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry (1982) 1.60
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
Oral tuberculosis. Br Dent J (2001) 1.55
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol (1989) 1.55
Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases. Biochemistry (1996) 1.55
Muscarinic regulation of intracellular signaling and neurosecretion in gonadotropin-releasing hormone neurons. Endocrinology (1998) 1.53
Spare gonadotrophin receptors in rat testis. Nat New Biol (1973) 1.51
Tuberculosis in the workplace: developing partnerships with the garment industries in Bangladesh. Int J Tuberc Lung Dis (2012) 1.51
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. J Med Chem (1991) 1.50
Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol (1990) 1.50
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther (1990) 1.50
Multiple pathways of inositol polyphosphate metabolism in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem (1988) 1.50
Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest (1993) 1.50
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors. J Med Chem (1992) 1.50
Binding sites for inositol trisphosphate in the bovine adrenal cortex. Biochem Biophys Res Commun (1985) 1.48
Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.48
Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem (1992) 1.47
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.46
Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol (1989) 1.45
Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci (1991) 1.45
Characteristics of a soluble gonadotropin receptor from the rat testis. J Biol Chem (1973) 1.41
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem (1982) 1.38
Metabolism of inositol 1,3,4-trisphosphate to a new tetrakisphosphate isomer in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem (1987) 1.38
Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J Pharmacol Exp Ther (1982) 1.38
Calcium signaling and episodic secretion of gonadotropin-releasing hormone in hypothalamic neurons. Proc Natl Acad Sci U S A (1992) 1.37
Pathways for the degradation of m-cresol and p-cresol by Pseudomonas putida. J Bacteriol (1975) 1.36
Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res (1989) 1.36
Localization of angiotensinogen messenger RNA in rat aorta. Circ Res (1988) 1.35
Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J Pharmacol Exp Ther (1981) 1.35
Evaluation of a yoga based regimen for treatment of osteoarthritis of the hands. J Rheumatol (1994) 1.35
Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst (1989) 1.34
Angiotensin II-forming activity in a reconstructed ancestral chymase. Science (1996) 1.34
Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res (1997) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol (1981) 1.33
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A (1999) 1.33
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J Med Chem (1996) 1.32
Mini-review. The postsynaptic alpha 2-adrenoreceptor. J Auton Pharmacol (1981) 1.32
Hormone-induced redistribution of calcium-activated phospholipid-dependent protein kinase in pituitary gonadotrophs. J Biol Chem (1985) 1.32
Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci U S A (1987) 1.31
Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases. J Biol Chem (1997) 1.29
Intermediate role of adenosine 3':5'-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells. Proc Natl Acad Sci U S A (1977) 1.29
Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol (1980) 1.29
Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg (1996) 1.28
Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. J Pharmacol Exp Ther (1983) 1.28
Angiotensin-stimulated production of inositol trisphosphate isomers and rapid metabolism through inositol 4-monophosphate in adrenal glomerulosa cells. Proc Natl Acad Sci U S A (1986) 1.28
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res (1992) 1.27
Mechanisms of endothelium-dependent vascular smooth muscle relaxation. Biochem Pharmacol (1985) 1.26
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem (1974) 1.25
The spatial mapping of translational diffusion coefficients by the NMR imaging technique. Phys Med Biol (1985) 1.25
Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocr Rev (1981) 1.24
Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.23
Inositol 1,3,4,5-tetrakisphosphate stimulates calcium release from bovine adrenal microsomes by a mechanism independent of the inositol 1,4,5-trisphosphate receptor. Biochem J (1990) 1.23
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension (1992) 1.23
A convenient optimized method for the analysis of selected solvent vapors in the industrial atmosphere. Am Ind Hyg Assoc J (1970) 1.23
Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science (1989) 1.23
Novel aspects of gonadotropin-releasing hormone action on inositol polyphosphate metabolism in cultured pituitary gonadotrophs. J Biol Chem (1987) 1.22
Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem Biophys Res Commun (1992) 1.22
Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines. Eur J Clin Invest (1987) 1.21
Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet (1973) 1.21
Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). Biochemistry (1998) 1.21
Kinetics of gonadotropin binding by receptors of the rat testis. Analysis by a nonlinear curve-fitting method. Biochemistry (1975) 1.20
Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem (1995) 1.20
Internalisation of gonadotrophin--receptor complex in ovarian luteal cells. Nature (1978) 1.20
Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor. J Biol Chem (1999) 1.19
Cardiovascular effects and interaction with adrenoceptors of urapidil. Arch Int Pharmacodyn Ther (1985) 1.18